Exploring the appeal and risks of oral nicotine products among young adult e-cigarette users
Official title: The Effect of Flavor and Nicotine Strength on the Abuse Liability and Appeal of Oral Nicotine Products
Run by University of Southern California · NCT06506162 · Data updated 2026-11-12
This study looks at how appealing and risky new oral nicotine products are for young adults who only use e-cigarettes to see how flavors and nicotine levels affect their choices.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 25 Years |
| Sex | All |
| Enrollment | 320 (estimated) |
| Sponsor | University of Southern California Academic / other |
| Locations | 2 sites (Los Angeles, California and 1 other locations) |
| Status | Recruiting |
| Started | February 9, 2024 |
| Main results expected | February 14, 2028 |
| Study ends | February 14, 2028 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06506162 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are young adults aged 21-25 who are current exclusive e-cigarette users and have never used any oral nicotine products.
✕Probably not a fit
Patients who are not exclusive e-cigarette users or those who have used oral nicotine products in the past will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the appeal and potential abuse liability of novel oral nicotine products (ONPs) among young adults who are current exclusive e-cigarette users. It focuses on understanding how factors such as flavor and nicotine concentration influence the use patterns of ONPs, particularly in the context of increasing regulatory restrictions on e-cigarettes. By examining these dynamics, the research aims to inform public health regulations that could mitigate the risks associated with dual use of e-cigarettes and ONPs. Participants will be young adults aged 21-25 who have been using e-cigarettes regularly and have never tried ONPs.
Why it matters
Potential benefit: If successful, this study could lead to better regulations that protect young adults from increased nicotine dependence due to dual use of e-cigarettes and oral nicotine products.
How similar studies have gone: While there is limited research specifically on oral nicotine products, studies on e-cigarettes and their appeal among young adults have shown significant findings, suggesting that this area of investigation is both relevant and timely.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. aged 21-25 years 2. current exclusive EC user (defined as at least weekly use over the past 3 months) and recent nicotine use confirmed by positive urine test (\>1 semiquantitative Total Nicotine Equivalent; see below) 3. not currently using another tobacco/nicotine product (defined as no use in the past 6 months) 4. have never used any ONP (medicinal or nonmedicinal) 5. willing to try study provided ONPs. Exclusion Criteria: 1. recent COVID-19+ (positive test in the past 30 days) 2. a recent COVID-19 hospitalization (past 3 months) 3. unstable or significant psychiatric conditions (past and stable conditions allowed) 4. history of cardiac event or distress within the past 3 months 5. currently pregnant (based on urine pregnancy test), planning to become pregnant, or breastfeeding.
Where it's running
-
University of Southern California
Los Angeles, California, United States Recruiting -
University of Southern California
Los Angeles, California, United States Recruiting
Study contacts
- Principal investigator: John R Monterosso, PhD — University of Southern California
- Study coordinator: John R Monterosso, PhD
- Email: johnrmon@usc.edu
- Phone: 3107099322
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel
This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.
-
Do a single nicotine pouch affect cigarette craving and brain response to smoking cues
This study tests whether a single 6 mg oral nicotine pouch can reduce craving and alter prefrontal brain responses to smoking cues in adults who smoke cigarettes.
-
TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping
This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.
-
Social media support groups to help teens and young adults quit vaping
This pilot tries a social-media group program called the Quit the Hit Toolkit to help adolescents and young adults who vape stop using nicotine.
-
Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients
This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.
-
Sex differences in how menthol e-cigarettes appeal to people who smoke
This study tests whether men and women differ in how menthol e-cigarettes with or without nicotine appeal to smokers who have used e-cigarettes before.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.